Detalhe da pesquisa
1.
Person-specific priorities in solitude.
J Pers
; 2024 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38279643
2.
Moral Frames Are Persuasive and Moralize Attitudes; Nonmoral Frames Are Persuasive and De-Moralize Attitudes.
Psychol Sci
; 33(3): 433-449, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35213257
3.
Urgent cytoreduction for newly diagnosed acute myeloid leukemia patients allows acquisition of pretreatment genomic data and enrollment on investigational clinical trials.
Am J Hematol
; 97(7): 885-894, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35413152
4.
Retrospective comparison of survival and responses to Fludarabine, Cytarabine, GCSF (FLAG) in combination with gemtuzumab ozogamicin (GO) or Idarubicin (IDA) in patients with newly diagnosed core binding factor (CBF) acute myelogenous leukemia: MD Anderson experience in 174 patients.
Am J Hematol
; 97(11): 1427-1434, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36053747
5.
Evaluating Belief System Networks as a Theory of Political Belief System Dynamics.
Pers Soc Psychol Rev
; 25(2): 159-185, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33655780
6.
Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab.
Blood
; 129(10): 1275-1283, 2017 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28003274
7.
Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G-CSF based regimens.
Am J Hematol
; 98(3): E53-E56, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36565294
8.
How to make replications mainstream.
Behav Brain Sci
; 41: e136, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31064518
9.
Persistence of minimal residual disease assessed by multiparameter flow cytometry is highly prognostic in younger patients with acute myeloid leukemia.
Cancer
; 123(3): 426-435, 2017 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27657543
10.
A randomized phase 2 study of idarubicin and cytarabine with clofarabine or fludarabine in patients with newly diagnosed acute myeloid leukemia.
Cancer
; 123(22): 4430-4439, 2017 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28708931
11.
Vosaroxin in combination with decitabine in newly diagnosed older patients with acute myeloid leukemia or high-risk myelodysplastic syndrome.
Haematologica
; 102(10): 1709-1717, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28729302
12.
Predicting Ideological Prejudice.
Psychol Sci
; 28(6): 713-722, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28394693
13.
Clinical Outcomes and Co-Occurring Mutations in Patients with RUNX1-Mutated Acute Myeloid Leukemia.
Int J Mol Sci
; 18(8)2017 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-28933735
14.
Allogeneic Transplantation in First Remission Improves Outcomes Irrespective of FLT3-ITD Allelic Ratio in FLT3-ITD-Positive Acute Myelogenous Leukemia.
Biol Blood Marrow Transplant
; 22(7): 1218-1226, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27058617
15.
Long-term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trial.
Br J Haematol
; 174(5): 760-6, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27301277
16.
Peripheral blood blast clearance is an independent prognostic factor for survival and response to acute myeloid leukemia induction chemotherapy.
Am J Hematol
; 91(12): 1221-1226, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27474808
17.
Results of phase 2 randomized study of low-dose decitabine with or without valproic acid in patients with myelodysplastic syndrome and acute myelogenous leukemia.
Cancer
; 121(4): 556-61, 2015 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25336333
18.
Final results of a phase 2 trial of clofarabine and low-dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemia.
Cancer
; 121(14): 2375-82, 2015 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25809968
19.
Clinical characteristics and outcomes in patients with acute promyelocytic leukaemia and hyperleucocytosis.
Br J Haematol
; 168(5): 646-53, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25312977
20.
The unthinking or confident extremist? Political extremists are more likely than moderates to reject experimenter-generated anchors.
Psychol Sci
; 26(2): 189-202, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25512050